CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Revenues
Product revenue, net	$ 582	$ 206
Operating expenses
Cost of goods sold	80	9
Research and development	11,401	27,800
Selling, general and administrative	13,264	23,595
Total operating expenses	24,745	51,404
Loss from operations	(24,163)	(51,198)
Other expense (income)
Interest expense	3,607	3,367
Interest income	(947)	(2,015)
Other (income) expense, net	(32)	246
Net loss	$ (26,791)	$ (52,796)
Basic net loss per share attributable to common stockholders (in dollars per share)	$ (0.87)	$ (1.84)
Diluted net loss per share attributable to common stockholders (in dollars per share)	$ (0.87)	$ (1.84)
Weighted average shares outstanding - basic (in shares)	30,868	28,616
Weighted average shares outstanding - diluted (in shares)	30,868	28,616